Clinical Trial Update: Intranasal SB-705498 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intranasal SB-705498 in healthy volunteers for rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinitis

Drugs mentioned

• SB-705498

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis | Phase 1 | Status: COMPLETED